Recruiting OBSERVATIONAL NCT07054125
Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes (COMPASS)
The COMPASS Program: Continuous Monitoring, Peer And Structured Support for Management of Uncontrolled Type 2 Diabetes - A Prospective Single-Arm Study
Sponsor: DexCom, Inc.
Conditions
Type 2 Diabetes Mellitus - Poor Control
Interventions
Education, lifestyle counseling, and peer support
Updated 1 time since 2025 Last updated: Jun 27, 2025 Started: Aug 1, 2025 Primary completion: Aug 31, 2027 Completion: Aug 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Type 2 Diabetes Mellitus - Poor Control and is currently actively recruiting participants. DexCom, Inc. leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- DexCom, Inc.
- Whole Endo
Data source: Whole Endo
For direct contact, visit the study record on ClinicalTrials.gov .